T

here was an excitement evident at this week’s meeting of stem cell scientists in Boston, with speakers highlighting how the years of toil in labs were approaching payoffs for patients, as more cell therapies have moved into clinical trials and researchers have gained a greater understanding of how to maximize their promise.

“This is our century,” Sally Temple, the president of the International Society for Stem Cell Research, said as thousands of experts milled about.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine